Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear
Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community.
| Condition(s) | Thyroid Cancer, Prostate Cancer, Neuroendocrine Tumors |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Development of a clinico-biological database allowing the provision of clinical data and corresponding biological materials to the medical and scientific community. |
| Who can participate | Inclusion Criteria: * Age ≥ at 18 years old, * Patient treated in the Nuclear Medicine Department for the treatment by metabolic radiotherapy, * Patient treated as part of his treatment for: * thyroid cancer, * a neuroendocrine tumor or * prostate cancer. * Patient having accepted the complementary blood sample, * Patient having given his informed, written and express consent. Exclusion Criteria: * Patient not affiliated to a social security scheme, * Subject under tutelage, curatorship or safeguard of justice, * Patient in an emergency situation * Patient whose regular monitoring is a priori impossible for psychological, family, social or geographical reasons, * Pregnant and / or breastfeeding woman |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Institut du Cancer de Montpellier - Val d'Aurelle |
| Locations | Bordeaux, Aquitaine, France; Marseille, Bouches Du Rhône, France; Montpellier, France; Toulouse, France |
| Start date | 2019-10-28 |
| NCT ID | NCT04104529 |
| Official listing | https://clinicaltrials.gov/study/NCT04104529 |